CONTEXT: Placental angiogenesis contributes to the pathogenesis of preeclampsia (PE) that affects 5-8% of all human pregnancies. MicroRNA (miRNA) are a class of noncoding 21- to 25-nucleotide RNA that negatively regulate gene expression posttranscriptionly. OBJECTIVE: The aim of this study was to test the hypothesis that miRNA are differentially expressed in healthy term and PE placentas and a subclass of angiogenesis-associated miRNA are increased by PE. DESIGN: Total miRNA were extracted from villous placental tissues from healthy term and severe preeclamptic pregnancies. Differential miRNA expression was analyzed by microarray and real-time quantitative PCR. Angiogenesis-associated miRNA were analyzed by target prediction databases. In situ hybridization was used to localize miRNA. Target verification was performed by transfection of miRNA precursors or antagomirs into endothelial and BeWo cells and luciferase reporter assays. RESULTS: Three highly expressed miRNA (miR-17, -20a, and -20b) were found significantly increased in PE compared with healthy term placentas (n = 10 per group). They target on the same group of genes important for angiogenesis. miR-20b was expressed primarily in villous syncytiotrophoblasts in term placenta. Overexpression or inhibition of miR-20b differentially regulated mRNA expression of those genes in endothelial vs. trophoblast cells. Luciferase reporter assay showed that miR-20b targets EPHB4 and ephrin-B2 that have been shown to be critical for early human placental development. Placental ephrin-B2 mRNA was significantly down-regulated in PE compared with normotensive pregnancies. CONCLUSION: miR-17, miR-20a, and miR-20b are differentially regulated in human placentas by PE. They regulate EPHB4 and ephrin-B2 expression in trophoblast and endothelial cells via the same "seed" sequence, suggesting their roles in early placental development.
CONTEXT: Placental angiogenesis contributes to the pathogenesis of preeclampsia (PE) that affects 5-8% of all human pregnancies. MicroRNA (miRNA) are a class of noncoding 21- to 25-nucleotide RNA that negatively regulate gene expression posttranscriptionly. OBJECTIVE: The aim of this study was to test the hypothesis that miRNA are differentially expressed in healthy term and PE placentas and a subclass of angiogenesis-associated miRNA are increased by PE. DESIGN: Total miRNA were extracted from villous placental tissues from healthy term and severe preeclamptic pregnancies. Differential miRNA expression was analyzed by microarray and real-time quantitative PCR. Angiogenesis-associated miRNA were analyzed by target prediction databases. In situ hybridization was used to localize miRNA. Target verification was performed by transfection of miRNA precursors or antagomirs into endothelial and BeWo cells and luciferase reporter assays. RESULTS: Three highly expressed miRNA (miR-17, -20a, and -20b) were found significantly increased in PE compared with healthy term placentas (n = 10 per group). They target on the same group of genes important for angiogenesis. miR-20b was expressed primarily in villous syncytiotrophoblasts in term placenta. Overexpression or inhibition of miR-20b differentially regulated mRNA expression of those genes in endothelial vs. trophoblast cells. Luciferase reporter assay showed that miR-20b targets EPHB4 and ephrin-B2 that have been shown to be critical for early human placental development. Placental ephrin-B2 mRNA was significantly down-regulated in PE compared with normotensive pregnancies. CONCLUSION:miR-17, miR-20a, and miR-20b are differentially regulated in human placentas by PE. They regulate EPHB4 and ephrin-B2 expression in trophoblast and endothelial cells via the same "seed" sequence, suggesting their roles in early placental development.
Authors: Jimmy Espinoza; John E Uckele; Robert A Starr; David E Seubert; Andres F Espinoza; Stanley M Berry Journal: Am J Obstet Gynecol Date: 2010-03-15 Impact factor: 8.661
Authors: Daniel A Enquobahrie; Margaret Meller; Kenneth Rice; Bruce M Psaty; David S Siscovick; Michelle A Williams Journal: Am J Obstet Gynecol Date: 2008-06-04 Impact factor: 8.661
Authors: Frank Noack; Julika Ribbat-Idel; Christoph Thorns; Andrea Chiriac; Roland Axt-Fliedner; Klaus Diedrich; Alfred C Feller Journal: J Perinat Med Date: 2011-02-10 Impact factor: 1.901
Authors: Marshall S Scicchitano; Deidre A Dalmas; Melissa A Bertiaux; Shawn M Anderson; Leah R Turner; Roberta A Thomas; Rossana Mirable; Rogely W Boyce Journal: J Histochem Cytochem Date: 2006-07-24 Impact factor: 2.479
Authors: Julio Mateus; Roger B Newman; Cuilin Zhang; Sarah J Pugh; Jagteshwar Grewal; Sungduk Kim; William A Grobman; John Owen; Anthony C Sciscione; Ronald J Wapner; Daniel Skupski; Edward Chien; Deborah A Wing; Angela C Ranzini; Michael P Nageotte; Nicole Gerlanc; Paul S Albert; Katherine L Grantz Journal: Am J Obstet Gynecol Date: 2019-06-19 Impact factor: 8.661
Authors: Qian Li; Maya A Kappil; An Li; Priyanthi S Dassanayake; Thomas H Darrah; Alan E Friedman; Michelle Friedman; Luca Lambertini; Philip Landrigan; Christopher J Stodgell; Yulin Xia; Jessica A Nanes; Kjersti M Aagaard; Eric E Schadt; Jeff C Murray; Edward B Clark; Nancy Dole; Jennifer Culhane; James Swanson; Michael Varner; Jack Moye; Carol Kasten; Richard K Miller; Jia Chen Journal: Epigenetics Date: 2015-08-07 Impact factor: 4.528